Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 juil. 2025 08h00 HE | Source: Route 92 Medical, Inc.

Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial

Route 92 Medical announced results from an independent real-world study of its HiPoint Reperfusion System and plans for a 500-patient SUMMIT RISE study.
21 mai 2025 08h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Route 92 Medical announces results of the SUMMIT MAX randomized clinical trial and receipt of a 510(k) clearance for the HiPoint 88 Reperfusion System.
27 mars 2025 08h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for its Portfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke

Route 92 Medical receives Australian Therapeutic Goods Administration approval for its portfolio of neurovascular interventional products.
19 mars 2025 09h00 HE | Source: Route 92 Medical, Inc.

First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension

First-of-its-kind multicenter study demonstrates the utility of the Monopoint system in procedures to treat idiopathic intracranial hypertension.
21 févr. 2024 08h00 HE | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial

Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.